Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: A basis for checklists

Archives of Pathology and Laboratory Medicine

Volumn 124, Issue 7, 2000, Pages 1034-1039

  Srigley, John R ^a   Amin, Mahul B ^b   Bostwick, David G ^c   Grignon, David J ^d   Hammond, M Elizabeth H ^e   Schramm, Joe ^f  

^a MCMASTER UNIVERSITY   (Canada)

^b EMORY UNIVERSITY   (United States)

^c BOSTWICK LABORATORIES   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f Molecular Pathology Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER INVASION; CANCER STAGING; HISTOPATHOLOGY; LABORATORY TEST; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; REVIEW; TUMOR VOLUME;

BIOPSY; CLINICAL PROTOCOLS; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PATHOLOGY, CLINICAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0033859846     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla A. Tumors of the Prostile Gland, Seminal Vesicle, Male Urethra and Penis. Washington, DC: Armed Forces Institute of Pathology. Atlas of Tumor Pathology, 3rd series. In press.
2. Gleason DR, Mellinger GT, the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostate adenocarcinoma by combined histological grading and clinical staging. J Urol. 1974;111:58-64.
3. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol. 1992;23:273-279.
4. Bostwick DG. Gleason grading of prostatic needle biopsies: correlation with grade in 316 matched prostatectomies. Am J Surg Pathol. 1994;18:796-803.
5. Steinberg DM, Sauvageot J, Piantadosi S, Epstein JI. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol. 1997;21:566-576.
6. Partin AW, Kattan MW, Subong ENP, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA. 1997;277:1445-1451.
7. Epstein JI. The diagnosis and reporting of adenocarcinoma of the prostate in core needle biopsy specimens. Cancer. 1996;78:350-356.
8. Amin MB, Grignon D, Bostwick D, et al. Recommendations for reporting resected prostatic carcinomas with commentary. Pathol Case Rev. 1998;3:223-232.
9. Bostwick DG. Evaluating prostate needle biopsy: therapeutic and prognostic importance. CA Cancer J Clin. 1997;47:297-319.
10. Cupp MR, Bostwick DG, Myers RP, Oesterling JE. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy on an individual basis. J Urol. 1995;153:1543-1548.
11. Peller PA, Young DC, Marmaduke DP, et al. Sextant prostate biopsies: a histopathologic correlation with radical prostatectomy specimens. Cancer. 1995; 75:530-538.
12. Ravery V, Boccon-Gibod LA, Dauge-Geffroy, et al. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology. 1994;44:371-376.
13. Ravery V, Schmid HP, Toublanc M, Boccon-Gibod L. Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma? Cancer. 1996;78:1079-1084.
14. Terris MK, Haney DJ, Johnstone IM, et al. Prediction of prostate cancer volume using prostate specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology. 1995;45:75-80.
15. Stamey TA, Freiha FS, McNeal JE, et al. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer. 1993;71;933-938.
16. Humphrey PA, Vollmer RT. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol. 1997;10:325-333.
17. Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol. 1993;17:1252-1261.
18. Anderson PR, Hanlon AI, Patchefsky A, Al-Saleem T, Hanks GE. Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy. Int J Radiat Oncol Biol Phys. 1998;41:1087-1092.
19. Bastacky SI, Walsh PC, Epstein JI. Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol. 1993;17:336-341.
20. Holmes GF, Walsh PC, Pound CR, Epstein JI. Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy. Urology. 1999;53:752-756.
21. Vargas SO, Jiroutek M, Welch MR, et al. Perineural invasion in prostate needle biopsy specimens: correlation with extraprostatic extension at resection. Am J Clin Pathol. 1999;111:223-228.